Stock Events

Stock Events

Monopar Therapeutics (MNPR) Q4 2024 Earnings

8NovConfirmed

Q3 2023

Q2 2024

Q3 2024

Q4 2024

-1

-0.7

-0.4

-0.1

Details

Expected EPS

-0.995

Actual EPS

-0.37

Surprise EPS

0.63

Surprise Percent

+62.81%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.37 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.